Rory Ritts
Papers
1
Total Citations
3
H-Index
1
About
Dr. Rory Ritts is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for upper tract urothelial carcinoma (UTUC). His most impactful work provides a critical, evidence-based comparison of open, laparoscopic, and robotic radical nephroureterectomy (RNU). In his highly cited 2025 study, Dr. Ritts not only evaluated surgical outcomes and costs across these three approaches but also introduced and assessed the clinical relevance of the "tetrafecta"—a novel composite outcome measure designed to capture a more holistic picture of surgical success and its impact on patient survival. This contribution has been instrumental in guiding surgical decision-making and standardizing quality assessment in UTUC care. With his work garnering significant attention in the field, Dr. Ritts is recognized for advancing the understanding of minimally invasive techniques and for developing robust metrics that better predict long-term oncologic control, directly shaping contemporary urologic practice.
Research Focus
Key Achievements
Top Papers
- 1